VEGFA and cancer: EDPs potently inhibit cancer growth, neovascularization, and metastasis both in vivo and in vitro [61], due to the inhibition of vascular endothelial growth factor (VEGF)- and fibroblast growth factor 2-induced angiogenesis (Figure 4).